Diabetes is one of the most common chronic illnesses in the United States, affecting the lives of tens of millions of Americans. There is a clear link between Testosterone Deficiency and Diabetes, and researchers from the University at Buffalo hypothesize that Testosterone Injections may be an effective addition to Diabetes Treatment.
Not that long ago, Type-2 Diabetes was considered a permanent condition. On the other hand, a growing selection of research shows that Type-2 Diabetes can be greatly mitigated and even reversed with the correct treatment combined with appropriate lifestyle changes.
Dr. Paresh Dandona Presents New Data Regarding Testosterone as a Type-2 Diabetes Treatment
Dr. Paresh Dandona is the co-author of the research, printed in the scientific periodical Diabetes, Obesity, and Metabolism. The title is "Remission of type 2 diabetes following long-term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11-year data from a real-world registry study."
This study collected data from eleven years of treatment at a facility in Bremerhaven, Germany. Bio-Identical Testosterone Therapy cured Type-2 Diabetes in 1/3rd of treated patients. Based on this data, Dr. Dandona is confident that Testosterone can help men overcome Diabetes, increase insulin sensitivity, and burn body fat. The research is making waves around the world, as Dr. Dandona was highly lauded in India for his research at the 2020 Mohan Diabetes Foundation Symposium.
What is Type-2 Diabetes?
Type-2 Diabetes is a disorder of the pancreatic system which prevents the body from adequately controlling blood sugar. It's also known as Adult-Onset Diabetes or Diabetes Mellitus Type 2. Blood Glucose Levels elevate because the body can't produce enough Insulin to lower Blood Sugar, largely due to rising insulin resistance. Testosterone Deficiency is common among Type-2 Diabetics, affecting around 1/3rd of men with the condition. It's estimated that more than 3,000,000 are diagnosed with Type-2 Diabetes every year.
The Link Between Type-2 Diabetes and Low-T
Dandona's research team first linked Type-2 Diabetes to Testosterone Deficiency in 2004. They also discovered that 25% of obese males without Diabetes also have Hypogonadism. It's estimated that Obesity and Type-2 Diabetes are the two leading causes of Testosterone Deficiency in men. Research published in 2016 by Dandona and others showed that Low-T Treatment with Bio-Identical Testosterone could reverse Insulin Resistance in a large cohort of patients. As Low-T has been shown to increase Insulin Resistance, it makes sense that Testosterone Therapy would restore Insulin Sensitivity.
In the most recently published study, the goal was to establish the effects of Testosterone Therapy on patients with comorbid Type-2 Diabetes and Low-T. Researchers sought to analyze the extent to which Testosterone Injections could reduce Insulin Resistance and help control blood sugar. They hypothesized that some patients could be cured of Type-2 Diabetes with effective treatment.
Testosterone Therapy for Type-2 Diabetics - Collecting Data
This study followed the treatment of 356 male patients. The same Urology Clinic treated all patients for eleven consecutive years. All patients were provided the standard treatment for Diabetes, but 178 patients also received Testosterone Injections. Of these 178, the average age of the men was 62, and patients received a 1 gram injection of Testosterone Undecanoate once every three months (after a six-week booster). The other 178 patients opted not to receive Testosterone Injections and had an average age of 64.
Patients were thoroughly analyzed regarding various factors associated with health and wellness, including Total Testosterone, Lipid Profile, Heart Rate, Insulin, HbA1c, Resting Glucose, Blood Pressure, waist circumference, weight, and height. Sexual Function and Quality of life were also recorded. Quality of Life was assessed via the Aging Males' Symptoms questionnaire. This data was collected a minimum of two times per year.
Testosterone for Type-2 Diabetes Results
The benefits were abundantly clear for patients receiving Testosterone Injections. Over the course of treatment, patients lost weight, had healthier resting blood sugar, lower resting insulin levels, and had lower HbA1c. On the other hand, patients that opted out of Testosterone had higher fasting insulin, HbA1c, and fasting glucose.
Among the experimental group, over 1/3rd experienced full relief from Diabetes. Furthermore, 46.6% of these patients could control blood sugar with a combo of Testosterone Therapy and Diabetes Treatment. Among these 178 patients, 83.1% met their HbA1c target. On the other hand, Control Patients experienced no cases of remission and had no reduction in HbA1c or blood sugar.
Patients taking Testosterone for Diabetes also had lower mortality risk and fewer diabetic complications, strokes, or heart attacks. This research makes it clear that the appropriate research should be conducted to ensure that patients with Type-2 Diabetes have access to the best possible treatments to live and thrive.
The study's authors note that 1/3rd of men suffer from Low-T and Type-2 Diabetes simultaneously. While Diabetes can cause Low-T, Testosterone Deficiency exacerbates the symptoms and increases the severity of Diabetes.
The discovery that Testosterone Replacement Therapy can effectively treat Type-2 Diabetes is groundbreaking. Further research is being conducted now and planned in the future to ensure the safety and effectiveness of this treatment.
- Low-T: What are healthy levels of Testosterone and why is it difficult to measure? - July 14th, 2020
- Important Facts About Testosterone Therapy Before Buying - July 13th, 2019
- Natesto Testosterone Spray: Are you having fertility problems? - July 9th, 2019
- A Recent Study Concludes: Testosterone DOES NOT Cause Prostate Cancer - June 27th, 2019
- Think Testosterone has no Health Benefits? Think Again! - June 26th, 2019
- LabCorp Announces a Change to the Testosterone Reference Range - June 23rd, 2019
- Sex Hormone-Binding Globulin - April 6th, 2019
- Testosterone Replacement Does Not Cause Heart Attacks - April 4th, 2019
- Did You Know: Low Testosterone Levels Can Predict Metabolic Syndrome - March 10th, 2019
- Testosterone: The Master Protector - February 26th, 2019
- Did You Know? Recent Studies Have Confirmed the Link Between Low Testosterone (“Low-T”) and Depression. - January 31st, 2019
- New Study Finds Testosterone Does Not Increase Your Heart Attack Risk - January 31st, 2019
- The Thyroid Gland: An Unsung Hero - January 29th, 2019
- Fed Up With Looking in the Mirror and Not Liking What You See? - January 27th, 2019
- Judge Vacates $140 Million Verdict in Testosterone Lawsuit - January 26th, 2019
- The Great Testosterone Debate - January 25th, 2019
- In the Battle Against Aging, When do the Risks Outweigh the Rewards? - December 25th, 2018
- Low-T and Older Men: Twice the Risk for Health Problems - November 27th, 2018
- Testosterone Therapy — Good Idea or Not? - November 19th, 2018
- Menopause: It's Not Just a Woman's Problem - November 19th, 2018
- Testosterone Replacement Therapy Lowers Heart Attack Risk - November 17th, 2018
- Think women don’t need testosterone? Think again! - November 17th, 2018
- Testosterone Replacement Therapy (TRT) May Prevent Heart Attacks and Diabetes - November 16th, 2018
- New Study Concludes: Boosting Testosterone Levels Lowers Men's Death Risk - November 16th, 2018
- More Reasons to Consider Testosterone Replacement Therapy - November 16th, 2018
- Testosterone Replacement Therapy: A Medical Alternative to Bariatric Surgery? - November 16th, 2018
- Male Menopause. Fact or Fiction ? - November 16th, 2018
- New Study Says: The Benefits of Testosterone Replacement Therapy Outweigh The Risks - November 16th, 2018
- The Facts You Need to Know About Testosterone - January 11th, 2018
Contact Us Today For A Free Consultation
Once you have completing the above contact form, for security purposes and confirmation, please confirm your information by calling us.
Please call now: 1-800-380-5339.
Welcoming You To Our Clinic, Professor Tom Henderson.
Word Count: 834